2J6 Stock Overview
MPX International Corporation, operates as a cannabis company in Canada and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
MPX International Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.0005 |
| 52 Week High | CA$0.001 |
| 52 Week Low | CA$0.0005 |
| Beta | 0 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | -98.88% |
| 5 Year Change | n/a |
| Change since IPO | -99.89% |
Recent News & Updates
Recent updates
Shareholder Returns
| 2J6 | DE Pharmaceuticals | DE Market | |
|---|---|---|---|
| 7D | 0% | 0.1% | -1.9% |
| 1Y | n/a | -29.2% | 1.1% |
Return vs Industry: Insufficient data to determine how 2J6 performed against the German Pharmaceuticals industry.
Return vs Market: Insufficient data to determine how 2J6 performed against the German Market.
Price Volatility
| 2J6 volatility | |
|---|---|
| 2J6 Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 7.1% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 9.9% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 2J6 has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine 2J6's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2015 | n/a | William Boyes | mpxinternationalcorp.com |
MPX International Corporation, operates as a cannabis company in Canada and internationally. It offers cannabis products under HOLYWEED, beleaf, SALSUS, MPX labs, Canveda, SPARTAN WELLNESS, HIGH12, STRAIN REE, PENNIES, Kingsway, DAIZE, and alice brands. The company was founded in 2015 and is headquartered in Toronto, Canada.
MPX International Corporation Fundamentals Summary
| 2J6 fundamental statistics | |
|---|---|
| Market cap | €482.75k |
| Earnings (TTM) | -€18.97m |
| Revenue (TTM) | €4.48m |
0.0x
P/S Ratio0.0x
P/E RatioIs 2J6 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 2J6 income statement (TTM) | |
|---|---|
| Revenue | CA$6.69m |
| Cost of Revenue | CA$3.37m |
| Gross Profit | CA$3.33m |
| Other Expenses | CA$31.68m |
| Earnings | -CA$28.36m |
Last Reported Earnings
Mar 31, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did 2J6 perform over the long term?
See historical performance and comparison